Last updated:
9/26/2024
Years published: 1994, 1998, 2000, 2003, 2011, 2015, 2018, 2024
NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders and Philippe Campeau, MD, FCCMG, Clinical Assistant Professor, Department of Pediatrics, University of Montreal, for assistance in the preparation of this report.
Wildervanck syndrome, also known as cervicooculoacoustic syndrome, is a rare genetic disorder that primarily affects females. The disorder is characterized by a skeletal condition known as Klippel-Feil syndrome (KFS); abnormalities of certain eye (ocular) movements (i.e., Duane syndrome); and/or hearing impairment that is present at birth (congenital). In individuals with KFS, there is abnormal union or fusion of two or more bones of the spinal column (vertebrae) within the neck (cervical vertebrae). Duane syndrome is characterized by limitation or absence of certain horizontal eye movements; retraction or “drawing back” of the eyeball into the eye cavity (orbit) upon attempting to look inward; and, in some people, abnormal deviation of one eye in relation to the other (strabismus). In some affected individuals, additional physical abnormalities may also be present. In most people, Wildervanck syndrome appears to occur randomly for unknown reasons (sporadically).
Wildervanck syndrome can present with a wide range of symptoms, and not all individuals will have the same issues. Usually, Wildervanck syndrome is characterized by three main findings (however, not everyone with Wildervanck syndrome has all three of these symptoms):
Researchers have identified three subtypes of Klippel-Feil syndrome (KFS) in Wildervanck syndrome:
People with KFS may have an unusually short neck. In severe cases, the head may appear to sit directly on the body. This condition can limit head and neck movement and cause a low hairline at the back of the head that may extend to the shoulders. The face might appear uneven from one side to the other (facial asymmetry) and the neck may be twisted (torticollis) with the head tilted to one side.
There is also a risk of neurological complications from unstable vertebrae in the neck, which could cause spinal cord injury either spontaneously or after minor trauma. These complications might include:
Other signs and symptoms may include:
While most individuals with Wildervanck syndrome have normal intelligence, intellectual disability has been reported in some patients. Additionally, some people with the syndrome may have short stature, and one person was diagnosed with a growth hormone deficiency.
In most patients, Wildervanck syndrome appears to occur randomly for unknown reasons (sporadically).
According to other researchers, Wildervanck syndrome may result from the interaction of several different genes (polygenic inheritance), possibly in combination with certain environmental factors (multifactorial inheritance) with limitation to females.
There is a report in the medical literature describing one affected person who had a small loss (deletion) of a region located at the short arm (p) of the chromosome X (the Xp26.3 region) and others have suggested that it may be caused by changes (variants) in the FGF13 gene.
Because the disorder primarily affects females, some researchers suggest that Wildervanck syndrome may be transmitted in an X-linked dominant pattern. X-linked dominant disorders are caused by a disease-causing gene variant on the X chromosome and mostly affect females. Females are affected when they have an X chromosome with the gene variant. Males with a disease-causing gene variant for an X-linked dominant disorder are more severely affected than females and often do not survive.
Since the disorder was originally described in 1952 (L.S. Wildervanck), almost 90 patients have been reported in medical literature. As mentioned above, Wildervanck syndrome primarily affects females. According to some reports, approximately one percent of females with hearing impairment may be affected by Wildervanck syndrome.
Wildervanck syndrome may be detected at birth or during the first year of life based upon a thorough clinical evaluation, identification of characteristic physical findings and specialized tests. Diagnostic studies may include advanced imaging techniques, such as computerized tomography (CT) scanning or magnetic resonance imaging (MRI). During CT scanning, a computer and x-rays are used to create a film showing cross-sectional images of internal structures. An MRI uses a magnetic field and radio waves to form detailed cross-sectional images of certain organs and tissues. Such techniques may help to detect and characterize abnormalities of the inner ear, union or fusion of certain bones of the spinal column (e.g., cervical vertebrae), possible impingement of vertebrae on the spinal cord, or other abnormalities potentially associated with the disorder.
In addition, in some individuals with Wildervanck syndrome, exploratory surgery may be conducted to detect malformations of the middle ear (exploratory tympanotomy). Additional specialized tests may also be performed to confirm or characterize other abnormalities that may be associated with the disorder (such as certain ocular findings, congenital heart defects, renal abnormalities, etc.).
Because of publications showing a possible relationship with variants in certain genes, it may be useful to have genetic testing.
Treatment
The treatment of Wildervanck syndrome is directed toward the specific symptoms and physical findings that are present in each individual. Such therapies may require the coordinated efforts of a team of medical professionals who may need to systematically and comprehensively plan an affected child’s treatment. These may include pediatricians; physicians who diagnose and treat disorders of the skeleton, muscles, joints, and related tissues (orthopedists); eye specialists (ophthalmologists); hearing specialists (e.g., otologists and audiologists); physicians who diagnose and treat heart abnormalities (cardiologists); surgeons and/or other health care professionals.
Because some affected individuals with abnormal union or fusion of certain cervical vertebrae may have an increased risk of neurological complications, they should be regularly monitored by physicians. In addition, they should avoid activities that may lead to trauma or injury to cervical vertebrae.
In some individuals with Wildervanck syndrome, treatment measures may include surgical repair of certain abnormalities. For example, middle ear surgery may be recommended for some individuals with conductive hearing loss. Ocular surgery may help to improve or correct impairment of certain eye movements. In addition, for those with cervical spinal cord compression, surgery may be conducted to correct such compression or associated vertebral instability. Surgical measures may also be recommended for other skeletal, ocular, auditory, cardiac, or other abnormalities potentially associated with Wildervanck syndrome. The surgical procedures performed will depend upon the severity of the anatomical abnormalities, their associated symptomsand other factors.
In addition, some affected individuals with hearing impairment may benefit from the use of specialized hearing aids. Other treatment for Wildervanck syndrome is symptomatic and supportive.
In some children, early intervention may be important in ensuring that child with Wildervanck syndrome reaches their potential. Special services that may be beneficial include special education, physical therapy and/or other medical, social, and/or vocational services. Genetic counseling may be helpful for individuals with Wildervanck syndrome and their families.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
Some current clinical trials also are posted on the following page on the NORD website:
https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/
For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com
For more information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/
JOURNAL ARTICLES
Chima-Galán MDC, Sánchez-Beltrán NA, García-Ortiz L. Wildervanck syndrome: clinical case report. Arch Argent Pediatr. 2023 Jun 1;121(3):e202202624. English, Spanish. https://www.sap.org.ar/docs/publicaciones/archivosarg/2023/v121n3a04e.pdf
Abu-Amero KK, Kondkar AA, Alorainy IA, et al. Xq26.3 microdeletion in a male with Wildervanck Syndrome. Ophthalmic Genet. 2014;35(1):18-24. doi:10.3109/13816810.2013.766218
Kumar A, Sahu A, Shetty S, Vijayalakshmi P. Wildervanck syndrome associated with cleft palate and short stature. Indian J Ophthalmol. 2010 Jul-Aug;58(4):323-5.
Dirik E, Yis U, Dirik MA, Cakmakçi H, Men S. Vertebral artery dissection in a patient with Wildervanck syndrome. Pediatr Neurol. 2008 Sep;39(3):218-20.
Oe K, Mori K, Konno T, Yoneda T, Ueyama K, Yamagishi M. Ruptured aneurysm of the sinus of Valsalva with Wildervanck syndrome (cervico-oculo-acoustic syndrome), blepharoptosis and short stature: case report. Circ J. 2007 Sep;71(9):1485-7.
Tubbs RS, Oakes WJ, Blount JP. Isolated atlantal stenosis in a patient with idiopathic growth hormone deficiency, and Klippel-Feil and Duane’s syndromes. Childs Nerv Syst. 2005 May;21(5):421-4. Epub 2004 May 7.
Balci S, Oguz KK, Firat MM, Boduroglu K. Cervical diastematomyelia in cervico-oculo-acoustic (Wildervanck) syndrome: MRI findings. Clin Dysmorphol. 2002 Apr;11(2):125-8.
Imaizumi K. [Wildervanck (cervico-oculo-acoustic) syndrome]. Ryoikibetsu Shokogun Shirizu. 2001;(33):361-2.
Smith SD, et al. Single gene influences on radiologically-detectable malformations of the inner ear. J Commun Disord. 1998;31:391-408.
Wang Y, et al. Wildervanck or cervico-oculo-acoustic syndrome. Lin Chuang Erh Pi Yen Hou Ko Tsa Chih. 1997;11:499-501.
Kumar A, et al. Wildervanck syndrome. Australas Radiol. 1996;40:160-161.
Johnson NA, et al. Wildervanck’s syndrome presenting as hemiparesthesia. Mil Med. 1995;160:208-211.
Kose G, et al. Cholelithiasis in cervico-oculo-acoustic (Wildervanck’s) syndrome. Acta Paediatr. 1993;82:890-891.
Gupte G, et al. Wildervanck syndrome (cervico-oculo-acoustic syndrome). J Postgrad Med. 1992;38:180-182.
Hughes PJ, et al. Wildervanck or cervico-oculo-acoustic syndrome and MRI findings. J Neurol Neurosurg Psychiatry. 1991;54:503-504.
Corsello G, et al. Cervico-oculo-acusticus (Wildervanck’s) syndrome: a clinical variant of Klippel-Feil sequence? Klin Padiatr. 1990;202:176-179.
NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View reportOnline Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.
View report